SciBase Holding AB (DE:5J3)
FRANKFURT:5J3
Germany Market
Holding DE:5J3?
Track your performance easily

SciBase Holding AB (5J3) Stock Price & Analysis

0 Followers

5J3 Stock Chart & Stats


Financials

Annual

5J3 FAQ

What was SciBase Holding AB’s price range in the past 12 months?
SciBase Holding AB lowest stock price was €0.00 and its highest was €0.09 in the past 12 months.
    What is SciBase Holding AB’s market cap?
    Currently, no data Available
    When is SciBase Holding AB’s upcoming earnings report date?
    SciBase Holding AB’s upcoming earnings report date is Nov 12, 2024 which is in 65 days.
      How were SciBase Holding AB’s earnings last quarter?
      SciBase Holding AB released its earnings results on Aug 21, 2024. The company reported -€0.007 earnings per share for the quarter, missing the consensus estimate of -€0.003 by -€0.003.
        Is SciBase Holding AB overvalued?
        According to Wall Street analysts SciBase Holding AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does SciBase Holding AB pay dividends?
          SciBase Holding AB does not currently pay dividends.
          What is SciBase Holding AB’s EPS estimate?
          SciBase Holding AB’s EPS estimate is >-€0.01.
            How many shares outstanding does SciBase Holding AB have?
            SciBase Holding AB has 219,538,400 shares outstanding.
              What happened to SciBase Holding AB’s price movement after its last earnings report?
              SciBase Holding AB reported an EPS of -€0.007 in its last earnings report, missing expectations of -€0.003. Following the earnings report the stock price went up 100%.
                Which hedge fund is a major shareholder of SciBase Holding AB?
                Currently, no hedge funds are holding shares in DE:5J3
                ---

                SciBase Holding AB Stock Smart Score

                Company Description

                SciBase Holding AB

                SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. Its first product, Nevisense, helps clinicians detect melanoma, the most dangerous type of skin cancer. The company operates in two segments: skin cancer and skin barrier assessment. Its geographical segments are Europe/Rest of the World, US/North America, and Asia/Oceania. It derives most of its revenue from the Europe/Rest of the World segment.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Metro AG
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis